Navigation Links
Celator Pharmaceuticals Raises Series C Financing in Excess of $22.5 Million
Date:7/28/2008

Financing will advance the company's clinical development programs and

CombiPlex(TM) technology platform

PRINCETON, N.J., July 28 /PRNewswire-FirstCall/ -- Celator Pharmaceuticals, a privately held pharmaceutical company developing novel products based on proven combinations of chemotherapeutic drugs, today announced that it raised in excess of $22.5 million in a Series C private equity financing.

All Series B investors participated in the financing and included; Domain Associates, Ventures West, Quaker BioVentures, TL Ventures, GrowthWorks Capital, and BDC Capital.

The proceeds will be used to fund Phase 2 studies of CPX-351 (a liposomal formulation of cytarabine:daunorubicin) in patients with acute myeloid leukemia. The company expects to start enrolling patients in a Phase 2 study of CPX-351 in newly diagnosed, elderly patients with AML before the end of 2008. Celator will continue to develop other CombiPlex(TM) products from its pipeline alone or in collaborations with pharmaceutical partners.

"This financing reflects the strong, continued support of our investors both in the company and our products," said Scott Jackson, chief executive officer of Celator Pharmaceuticals. "Our goal is to extend and enhance the lives of people with cancer. As a result, we have developed an oncology product pipeline that has significant commercial potential. These funds will allow us to conduct additional clinical trials and generate data that we believe will enable strategic partnerships with leading biotech and pharmaceutical companies."

Celator reported encouraging interim Phase 1 data with CPX-351 in December 2007 where complete remissions were obtained in patients with advanced leukemia. The company plans to submit additional CPX-351 pre-clinical and clinical data to this year's American Society of Hematology (ASH) meeting in December. In addition, positive Phase 2 clinical study results were reported for CPX-1
'/>"/>

SOURCE Celator Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Celator(R) Pharmaceuticals Reports CPX-351 Shows Anti-Cancer Activity in Leukemia Patients
2. Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations
3. Celator(R) Pharmaceuticals Announces Positive Phase 2 Results for CPX-1 in Treatment of Colorectal Cancer
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... , BLOOMINGTON, Minn, Nov. 27 A...edical image management software, data migration t... United States Patent and Trademark Office has app...tion Format within a Computer Network." Acuo Techn...ortfolio of intellectual property. In general, the...
(Date:11/25/2009)... , WESTON, Fla., Nov. 25 /PRNewswire-Fir...k Sheets: ASFX) ("the Company") is pleased to anno...d production management office in Shanghai, China....ad, providing an essential gateway for the develop...nd safety products for children and adults to be d...
(Date:11/25/2009)... , PHILADELPHIA, Nov. 25 /PRNewswire-Firs...at Dr. Michael J. McKelvey, the Company,s Presiden...ive Vice President and CFO, are scheduled to prese...nference at 1:30 PM EST on December 1, 2009 in New... access the presentation by visiting the Company,s...
Breaking Medicine Technology:Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2American Scientific Resources Inc. Opens Shanghai Location 2ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2JCI table of contents 3A Oct 19 2009 59769 1JCI table of contents 3A Oct 19 2009 59769 2JCI table of contents 3A Oct 19 2009 59769 3Childrens blood lead levels linked to lower test scores 10422 1Childrens blood lead levels linked to lower test scores 10422 2Research with wood ducks earns graduate student 2 national awards 10420 1
(Date:11/27/2009)...ed medical, economic burdens, study predicts , ...umber of people with diabetes in the United States...ew study predicts. , That would bring the total...ease, up from 23.7 million today. , , At the sam...will triple, the study also warns, rising from an ...
(Date:11/27/2009)...rpose bilingual coloring books designed for childr...community to educate - inform parents and children... to Dinosuars to ABC,S and a host of other topics....) November 27, 2009 -- Today’s children have...busy any hour of the day, but one of the oldest an...
(Date:11/26/2009)...ewswire/ -- With cold and flu season upon us, it,s... to control the spread of infections and avoid ill...eep ourselves healthy, but to avoid transmitting i..., CIC (certified in infection-control), nursing di...th at Hospital for Special Surgery (HSS) in Manhat...
(Date:11/26/2009)...rathiomolybdate (TM) has been shown in studies to ... disease caused by an overload of copper, and cert...ittle, however, is known about how the drug works ...thwestern University researchers now has provided ...e of TM bound to copper-loaded metallochaperones. ...
(Date:11/26/2009)...letters from the North Pole, Textsanta.net lets pa...Santa , North Pole, AK (P...ciencies at the North Pole Santa Claus has added S...he globe informed of his Christmas progress at the...epartment have identified a large and growing perc...
Breaking Medicine News(10 mins):Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2
...ial result it is said that the dietary supplement ...g is used as an alternative to reduce cholesterol....and sometimes from beeswax, wheat germ and rice br...ity of Cologne, Germany. The drug contains alcoho...
... of obese individuals expressed that they would ra...g fat//. The following is the result of an online ...y and Obesity at Yale. The 4,000 respondents...essed, or become alcoholic rather than be obese. F...
... that cardiovascular clinical trials published bet...ng on whether they were funded by for-profit //org...e were the finding of a study in the May 17 issue ... (FP) organizations were more likely to report pos...
...Research Organization (ISRO) announced expansion o... more speciality hospitals in the country.// Manip... Delhi, Venkatrao Dawle Medical Foundation in Maha...rimental basis, is aimed at linking remote or rura...
...archers at the University of Pennsylvania and Temp... 2 (PAI-2) plays an important role in diseases of ...and the tissue covering the eyes.// The researche...e for Cancer Research at Temple University (http:/...
...found a link between the signaling pathways in the...ion between the immune and the nervous system.// T...for a potential HIV treatment that could effective...of Pennsylvania appears in the Proceedings of the ...
Other Medicine News:Health News:Fat People Claim That They Would Give Their Limb Or Life Rather Than Being Fat 2Health News:Results of Clinical Trials Vary According to Source of Funding 2Health News:ISRO To Expand Telemedicine Network, 4 Speciality Hospitals To Be Included 2Health News:PAI-2 Plays a Pivotal Role in Eye Infections 2Health News:Link Between Immune System And Nervous System 2
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
Medicine Products: